Carobbio, Alessandra http://orcid.org/0000-0001-9664-7084
Vannucchi, Alessandro Maria
De Stefano, Valerio http://orcid.org/0000-0002-5178-5827
Masciulli, Arianna
Guglielmelli, Paola http://orcid.org/0000-0003-1809-284X
Loscocco, Giuseppe Gaetano http://orcid.org/0000-0002-6241-1206
Ramundo, Francesco
Rossi, Elena
Kanthi, Yogendra
Tefferi, Ayalew http://orcid.org/0000-0003-4605-3821
Barbui, Tiziano http://orcid.org/0000-0003-2747-6327
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (21267)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
Lasker Foundation
Article History
Received: 10 December 2021
Revised: 21 January 2022
Accepted: 26 January 2022
First Online: 10 February 2022
Competing interests
: AMV has personal fees as advisory board and speaker fee from AOP Orphan Pharmaceuticals, Incyte, BMS, and Novartis, outside the submitted work. VDS has personal fees as advisory board and speaker fee from AOP Orphan Pharmaceuticals, AbbVie, and Novartis, outside the submitted work. TB declares personal fees as advisory board from AOP Orphan Pharmaceuticals, Italfarmaco, and Novartis, outside the submitted work. YK is an author on a pending patent from the University of Michigan on use of biogases in vascular disease. The remaining authors declare no competing financial interests.